1
Gregor John McLennan Anderson, Stanley George Bonney, Anthony Patrick Jones, Duncan Robertson: Medicament delivery system. SmithKline Beecham Corporation, James P Riek, October 25, 2005: US06958691 (179 worldwide citation)

There is provided a system for the delivery of medicament comprising a medicament container; a dispensing mechanism for dispensing medicament from the medicament container; an electronic data management system; and a communicator for wireless communication with a network computer system to enable co ...


2

3

4
Davis Ward Ronda, Mook Robert Anthony Jr, Neeb Michael J, Salovich James M: Pyrimidine compounds. Smithkline Beecham Corporation, Davis Ward Ronda, Mook Robert Anthony Jr, Neeb Michael J, Salovich James M, LEVY David J, September 2, 2004: WO/2004/074244 (95 worldwide citation)

The present invention provides compounds of formula (I) : wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents.


5
Jose A Ortiz, Kenneth J Sylvester: Method and apparatus for automatically producing a plurality of sterile liquid filled delivery devices. SmithKline Beecham Corporation, Panitch Schwarze Jacobs & Nadel P C, March 23, 1999: US05884457 (86 worldwide citation)

A method of automatically producing a plurality of prefilled, sterile delivery devices with a desired quantity of fluid. The sterile delivery devices each include a hollow barrel with a dispensing nozzle at one end and an open opposite end. A piston plunger is positioned within the open end and is s ...


6
Michael N Gwynn, Howard Kallendar, Leslie M Palmer: Topoisomerase III. Smithkline Beecham Corporation, Edward R Gimmi, William T King, Arthur E Jackson, February 15, 2000: US06025156 (84 worldwide citation)

Topoisomerase III polypeptides and DNA and RNA encoding such Topoisomerase III polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Topoisomerase III for the treatment of infection, particularly bacterial i ...


7
George Stuart Cockerill, Malcolm Clive Carter, Stephen Barry Guntrip, Kathryn Jane Smith: Fused heterocyclic compounds as protein tyrosine kinase inhibitors. SmithKline Beecham Corporation, John L Lemanowicz, May 21, 2002: US06391874 (80 worldwide citation)

Substituted heteroaromatic compounds of formula (I) and in particular substituted quinolines and quinazolines, are protein tyrosine kinase inhibitors. The compounds are described as are methods for their preparation, pharmaceutical compositions including such compounds and their use in medicine, for ...


8
David P O Bryan, Kevin N Constable, Peter J Sagona, Bingham H Van Dyke Jr: Automated sampling and testing of biological materials. SmithKline Beecham Corporation, James M Kanagy, Stephen Venetianer, Edward T Lentz, April 22, 1997: US05623415 (80 worldwide citation)

This invention relates to an automated apparatus for subjecting samples to one or more selected test procedures at one or more test stations comprising a conveyor line for transporting samples contained in uniquely labeled containers, said line having at least two lanes for routing said containers t ...


9
Katherine Louisa Widdowson, Daniel Frank Veber, Anthony Joseph Jurewicz, Robert Philip Hertzberg, Melvin Clarence Rutledge Jr: IL-8 receptor antagonists. SmithKline Beecham Corporation, Dara L Dinner, Stephen Venetianer, Edward T Lentz, July 14, 1998: US05780483 (79 worldwide citation)

This invention relates to novel compounds and a novel use of phenyl ureas in the treatment of disease scates mediated by the chemokine, Interleukin-8 (IL-8). In particular, this invention relates to the novel compounds of Formula (Ia) and their use in treating chemokine mediated diseases wherein the ...


10